Supernus Pharmaceuticals SUPN
NASDAQ SUPN
$43.30 -0.67 (-1.52%)
As of: Sep 30, 2026 · 10:10 AM EDT

Supernus Pharmaceuticals (SUPN) Debt Ratio (2011 - 2023)

Updated

Supernus Pharmaceuticals' Debt Ratio was 0.27 in Q1 2023, up 13.7% from the prior quarter.

Analysis

Supernus Pharmaceuticals (SUPN) Debt Ratio (2011 - 2023) Analysis & Trends

For FY2022, Debt Ratio at Supernus Pharmaceuticals came in at 0.24, up 5.2% from FY2021.

  • In earlier years, Debt Ratio was 0.22 in FY2021.
  • The Q1 2023 figure marks the highest quarterly Debt Ratio since Q3 2012.
  • Per Business Quant data, SUPN's Debt Ratio in the three quarters before Q1 2023 was 0.24 (Q4 2022), 0.24 (Q3 2022) and 0.24 (Q2 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 0.24
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 0.52
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 0.42
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 0.31
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 0.00
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 0.60
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 0.53
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Supernus Pharmaceuticals 2.59 Bn 1.25 Bn 185.39 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 0.27
Dec 31, 2022 0.24
Sep 30, 2022 0.24
Jun 30, 2022 0.24
Dec 31, 2021 0.22
Mar 31, 2013 0.25
Dec 31, 2012 0.24
Sep 30, 2012 0.38
Jun 30, 2012 0.35
Mar 31, 2012 0.67
Dec 31, 2011 0.55
API Access

Supernus Pharmaceuticals Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=SUPN&period=max&api_key=YOUR_API_KEY